The Residual Risk Reduction Initiative

Your login
Your password
Confirm your password
Your email
I agree to receive the R3i newsletter
Yes No

Prof. Ele Ferrannini

Pisa School of Medicine
Pisa, Italy

Titles

Professor of Internal Medicine at the University of Pisa School of Medicine;
Chief of the Metabolism Unit of the CNR (National Research Council) Institute of Clinical Physiology, Pisa;
and Adjunct Clinical Professor of Medicine, Diabetes Division, University of Texas Health Science Center at San Antonio, Texas, USA

Professionnal education

Degree in Medicine (cum laude, at the University of Pisa School of Medicine, 1975);
Specialty Board Certification in Nuclear Medicine (cum laude, at the University of Pisa) and Diabetes&Metabolic Disease (cum laude, at the University of Torino, 1978);
Visiting Scientist at the Karolinska Institute, Stockholm, Sweden (1977-78);
and NIH Postdoctoral Research Fellowship at Yale University School of Medicine (1978-1982).

Publications

Over 500 original papers in the field of diabetes, metabolism and hypertension, and several reviews and textbook chapters.
On the list (ISIHighlyCited.com) of highly cited scientists.

Memberships

Founding member and Past-President of the Italian Society of Obesity; co-founder and Chairman of the European Group for the Study of Insulin Resistance (EGIR); Editor-in-Chief of the official Journal of EASD (Diabetologia, 1994-1997); Past-President of the European Association for the Study of Diabetes (EASD) and the European Foundation for the Study of Diabetes (EFSD) (2004-2008).

Current research areas

Insulin resistance and atherosclerosis; impact of oxidative stress and high blood pressure on endothelial function; autoimmunity in adult-onset diabetes; pathophysiology of insulin secretion; impact of hyperinsulinaemia on autonomic nervous system function; pathogenesis of the insulin, resistance and hyperinsulinism in obesity, and effects of weight loss; coronary atherosclerosis in diabetes; pathogenesis of the microvascular dysfunction and proteinuria in adult-onset diabetes.